Compare the effects of intravenous and intraperitoneal mesenchymal stem cell transplantation on ultrafiltration failure in a rat model of chronic peritoneal dialysis

References

• Danovitch GM, Cohen DJ, Weir MR, et al. Current status of kidney and pancreas transplantation in the United States, 1994–2003. Am J Transplant. 2005;5:904–915
   PubMed Web of Science ®Google Scholar
• Fusshoeller A. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis. Pediatr Nephrol. 2008;23:19–25
   PubMed Web of Science ®Google Scholar
• Margetts P, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int. 2003;23:530–541
   PubMed Web of Science ®Google Scholar
• Mortier S, De Vriese AS, Van de Voorde J, Schaub TP, Passlick-Deetjen J, Lameire NH. Hemodynamic effects of peritoneal dialysis solutions on the rat peritoneal membrane: Role of acidity, buffer choice, glucose concentration, and glucose degradation products. J Am Soc Nephrol. 2002;13:480–489
   Google Scholar
• Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470–479
   PubMed Web of Science ®Google Scholar
• Schilte MN, Celie JW, Wee PM, Beelen RH, van den Born J. Factors contributing to peritoneal tissue remodeling in peritoneal dialysis. Perit Dial Int. 2009;29:605–617
   PubMed Web of Science ®Google Scholar
• Duman S, Günal AI, Sen S, et al. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int. 2001;21:219–224
   Google Scholar
• Zareie M, Tangelder GJ, ter Wee PM, et al. Beneficial effects of aminoguanidine on peritoneal microcirculation and tissue remodelling in a rat model of PD. Nephrol Dial Transplant. 2005;20:2783–2792
   Google Scholar
• Aroeira LS, Aguilera A, Sánchez-Tomero JA, et al. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: Pathologic significance and potential therapeutic interventions. J Am Soc Nephrol. 2007;18:2004–2013
   PubMed Web of Science ®Google Scholar
• Yáñez-Mó M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med. 2003;348:403–413
   PubMed Web of Science ®Google Scholar
• Di Paolo N, Buoncristiani U, Capotondo L, et al. Phosphatidylcholine and peritoneal transport during peritoneal dialysis. Nephron. 1986;44:365–370
   Google Scholar
• Sun Y, Zhu F, Yu X, et al. Treatment of established peritoneal fibrosis by gene transfer of Smad7 in a rat model of peritoneal dialysis. Am J Nephrol. 2009;30:84–94
   Google Scholar
• Struijk DG, van der Reijden HJ, Krediet RT, Koomen GC, Arisz L. Effect of phosphatidylcholine on in peritoneal transport and lymphatic absorption in a CAPD patient with sclerosing peritonitis. Nephron. 1989;51:577–578
   Google Scholar
• Hür E, Bozkurt D, Sipahi S. Octreotide may prevent ultrafiltration failure in experimental peritonitis model. Turk Nephrol Dial Transpl. 2011;20:46–52
   Google Scholar
• Guo QY, Peng WX, Cheng HH, Ye RG, Lindholm B, Wang T. Hyaluronan preserves peritoneal membrane transport properties. Perit Dial Int. 2001;21:136–142
   Google Scholar
• Schilte MN, Loureiro J, Keuning ED, et al. Long-term intervention with heparins in a rat model of peritoneal dialysis. Perit Dial Int. 2009;29:26–35
   PubMed Web of Science ®Google Scholar
• Grzogorzewska AE. Protecting the peritoneal membrane in dialyzed patients. Adv Med Sci. 2006;51:191–196
   Google Scholar
• Nolph KD, Moore HL, Khanna R, Twardowski ZJ. Pentoxifylline does not influence maximum ultrafiltration rates and peritoneal transport in rats. Perit Dial Int. 1989;9:131–134
   Google Scholar
• Aroeira LS, Lara-Pezzi E, Loureiro J, et al. Cyclooxygenase-2 mediates dialysate-induced alterations of the peritoneal membrane. J Am Soc Nephrol. 2009;20:582–592
   Google Scholar
• Tanabe K, Maeshima Y, Ichinose K, et al. Endostatin peptide, an inhibitör of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model. Kidney Int. 2007;71:227–238
   PubMed Web of Science ®Google Scholar
• Nishino T, Miyazaki M, Abe K, et al. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int. 2003;64:887–896
   PubMed Web of Science ®Google Scholar
• Guo H, Leung JC, Lam MF, et al. Smad7 transgene attenuates peritoneal fibrosis in uremic rats treated with peritoneal dialysis. J Am Soc Nephrol. 2007;18:2689–2703
   Google Scholar
• Fang D, Seo BM, Liu Y, et al. Transplantation of mesenchymal stem cells is an optimal approach for plastic surgery. Stem Cells. 2007;25:1021–1028
   PubMed Web of Science ®Google Scholar
• Picinich SC, Mishra PJ, Mishra PJ, Glod J, Banerjee D. The therapeutic potential of mesenchymal stem cells. Cell- and tissue-based therapy. Expert Opin Biol Ther. 2007;7:965–973
   PubMed Web of Science ®Google Scholar
• Bastug F, Gündüz Z, Tülpar S, et al. Mesenchymal stem cell transplantation may provide a new therapy for ultrafiltration failure in chronic peritoneal dialysis. Nephrol Dial Transplant. 2013;28:2493–2501
   Google Scholar
• Ueno T, Nakashima A, Doi S, et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-β1 signaling. Kidney Int. 2013;84:297–307
   PubMed Web of Science ®Google Scholar
• Mortier S, Lameire NH, De Vriese AS. Animal models in peritoneal dialysis research: A need for consensus. Perit Dial Int. 2005;25:16–24
   Google Scholar
• Kim CD, Kwon HM, Park SH, et al. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model. Ther Apher Dial. 2007;11:56–64
   Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Mortier S, Lameire NH. What happens to the peritoneal membrane in long-term peritoneal dialysis? Perit Dial Int. 2001;21:9–18
   Google Scholar
• Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470–479
   PubMed Web of Science ®Google Scholar
• Hekking LH, Zareie M, Driesprong BAJ. Better preservation of peritoneal morphologic features and defense in rats after longterm exposure to a bicarbonate/Lactate-buffered solution. J Am Soc Nephrol. 2001;12:2775–2786
   PubMed Web of Science ®Google Scholar
• Smit W, Schouten N, van den Berg N, Langedijk MJ, Struijk DG, Krediet RT; Netherlands Ultrafiltration Failure Study Group. Analysis of the prevalence and causes of ultrafiltration failure during long-term peritoneal dialysis: A cross-sectional study. Perit Dial Int. 2004;24:562–570
   PubMedGoogle Scholar
• Honda K, Hamada C, Nakayama M, et al.; Peritoneal Biopsy Study Group of the Japanese Society for Peritoneal Dialysis. Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: A quantitative study of peritoneal membrane morphology. Clin J Am Soc Nephrol. 2008;3:720–728
   PubMedGoogle Scholar
• Hekking LH, Zweers MM, Keuning ED, et al. Apparent successful mesothelial cell transplantation hampered by peritoneal activation. Kidney Int. 2005;68:2362–2367
   Google Scholar
• Bertram P, Tietze L, Hoopmann M, et al. Interperitoneal transplantation of isologous mesothelial cells for prevention of adhesions. Eur J Surg. 1999;165:705–708
   Google Scholar
• Hekking LH, Harvey VS, Havenith CE, et al. Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis. Perit Dial Int. 2003;23:323–330
   PubMedGoogle Scholar
• Di Paolo N, Sacchi G. Anatomy and physiology of the peritoneal membrane. Contrib Nephrol. 1990;84:10–26
   Google Scholar
• Di Paolo N, Sacchi G. Atlas of peritoneal histology. Perit Dial Int. 2000;20:5–96
   PubMed Web of Science ®Google Scholar
• Di Paolo N, Sacchi G, Vanni L, et al. Autologous peritoneal mesothelial cell implant in rabbits and peritoneal dialysis patients. Nephron 1991;57:323–331
   PubMedGoogle Scholar
• Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008;180:2581–2587
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells. 2007;25:1737–1745
   PubMed Web of Science ®Google Scholar
• Salem H, Thiemermann C. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells. 2010;28:585–596
   PubMed Web of Science ®Google Scholar
• Liu ZJ, Zhuge Y, Velazquez OJ. Trafficking and differentiation of mesenchymal stem cells. J Cell Biochem. 2009;106:984–991
   PubMed Web of Science ®Google Scholar
• McTaggart SJ, Atkinson K. Mesenchymal stem cells: Immunobiology and therapeutic potential in kidney disease. Nephrology. 2007;12:44–52
   PubMed Web of Science ®Google Scholar
• Kode JA, Mukherjee S, Joglekar MV. Mesenchymal stem cells: Immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy. 2009;11:377–391
   PubMed Web of Science ®Google Scholar
• Bang OY, Lee JS, Lee PH, Lee G. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57:874–882
   PubMed Web of Science ®Google Scholar
• Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007;25:2648–2659
   PubMed Web of Science ®Google Scholar
• Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for non-healing cutaneous wounds. Plast Reconstr Surg. 2010;125:510–516
   PubMed Web of Science ®Google Scholar
• Sekiguchi Y, Hamada C, Ro Y, et al. Differentiation of bone marrowderived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model. J Artif Organs 2012;15:272–282
   Google Scholar
• Kim YJ, Park HJ, Lee G, et al. Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through antiinflammatory action. Glia. 2009;57:13–23
   PubMed Web of Science ®Google Scholar
• Imberti B, Morigi M, Tomasoni S, et al. Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol. 2007;18:2921–2928
   PubMed Web of Science ®Google Scholar